Pneumagen commits to clinical trial development for Covid-19
Pneumagen (Holdings) Ltd announced a £4m investment for the clinical development of Neumifil for the prevention and treatment of Covid-19.
Search by tag: pneumagen
Drug shows promise against Covid-19
A new anti-viral drug developed by University spin out, Pneumagen, has had positive results in laboratory tests against Covid-19.